Hospital operator HCA Healthcare (NYSE: HCA) will be reporting earnings this Tuesday morning. Here’s what investors should know.

HCA Healthcare beat analysts’ revenue expectations by 3.3% last quarter, reporting revenues of $19.16 billion, up 9.6% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ full-year EPS guidance estimates and a beat of analysts’ EPS estimates.

Is HCA Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting HCA Healthcare’s revenue to grow 7.7% year on year to $19.69 billion, improving from the 5.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $7.47 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. HCA Healthcare has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.9% on average.

With HCA Healthcare being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unravel for healthcare providers & services stocks. However, there has been positive investor sentiment in the segment, with share prices up 2.9% on average over the last month. HCA Healthcare’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $488.76 (compared to the current share price of $472.75).

P.S. STOP buying the AI stocks everyone's talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.